University spinouts are the primary source of breakthrough hard tech — and they require investors who understand both the science and the transition to commercial company building.
• FailUp Capital Investment Team
The pattern is remarkably consistent across the history of deep tech company formation. A researcher at a leading university — MIT, Stanford, Caltech, Carnegie Mellon, Cambridge, ETH Zurich — makes a discovery that has potential commercial applications. The technology transfer office files patents. A graduate student or post-doctoral researcher, convinced of the technology's potential, decides to found a company. They navigate the licensing process, form an LLC, and begin the transition from academic researcher to founder.
This process has produced some of the most important technology companies in history. Google originated from a Stanford PhD research project. Genentech was founded on University of California research. Modern CRISPR gene editing companies trace to research at UC Berkeley and the Broad Institute. Solid-state battery companies emerged from Stanford and MIT laboratories. The list goes on, and the pattern is not accidental — university research is specifically designed to generate fundamental knowledge, and fundamental knowledge, when it identifies a physical or chemical principle that can be exploited commercially, creates opportunities that are genuinely novel and often defensible in ways that purely commercial innovation is not.
At FailUp Capital, our partnership with Alumni Ventures gives us privileged access to university research ecosystems at some of the world's leading institutions. This access is not merely a financial advantage — it shapes how we find deals, how we evaluate technology, and how we support the founders we back through the difficult transition from academic research to commercial company building.
Before a university research discovery can become a startup company, it must navigate the technology transfer process. University technology transfer offices (TTOs) are responsible for evaluating research discoveries, filing and managing patents, and licensing intellectual property to commercializing entities — including startup companies founded by the researchers themselves.
The technology transfer process varies enormously in quality and speed across institutions. The best TTOs — MIT's Technology Licensing Office, Stanford's Office of Technology Licensing — have decades of experience, deep networks of industry contacts, and sophisticated processes for evaluating commercial potential. They move relatively quickly, understand the needs of early-stage startups, and structure licenses in ways that give companies room to build. Less experienced TTOs can be slow, unreasonably rigid about equity stakes and licensing terms, and poorly calibrated to the realities of deep tech company building.
For investors, the TTO relationship shapes the IP position of a spinout company in fundamental ways. We pay careful attention to the completeness of the IP assignment from the university to the company, the exclusivity of the license, the field-of-use restrictions, the royalty structure, the milestone payments, and the reversion rights if the company fails to commercialize. An unfavorable IP arrangement can make a spinout company nearly uninvestable even if the underlying technology is excellent.
The single most important challenge in university spinout company building is the transition of the founding scientist from researcher to company leader. Academic research culture optimizes for different skills and habits than commercial company building. Researchers are trained to pursue the most intellectually interesting question, to communicate findings through peer-reviewed publications and conference presentations, to build collaborative networks within their discipline, and to manage the student-advisor relationship. None of these skills is particularly relevant to the job of CEO.
Running a company requires a different orientation: ruthlessly prioritizing the activities that create commercial value, communicating clearly and concisely with investors and customers who do not share the founder's scientific background, building a team of people with different skill sets and managing them effectively, and making decisions under uncertainty with imperfect information and real consequences. Many brilliant researchers discover that these challenges are harder for them than any problem they faced in the laboratory.
This does not mean that researchers cannot become outstanding CEOs — many do. But the transition requires intentional effort, good advisors, and often a co-founder or early executive hire with commercial skills that complement the technical founder's scientific expertise. At FailUp Capital, we invest significant time in understanding the founder's self-awareness about this transition and their plan for acquiring the skills or bringing in the people they lack.
University spinouts begin their commercial lives with an IP position that is in some ways stronger than typical startups and in other ways more complicated. The strength: the core technology has typically been developed over years of well-funded academic research, often producing multiple patents covering fundamental aspects of the technology as well as its applications. The complication: the IP was developed in an academic context, which means the patent claims may be broad and fundamental but also may leave gaps, may have been filed before commercial applications were well understood, and may require additional patent development to fully cover the commercial embodiment of the technology.
Building a defensible IP strategy for a university spinout requires working with the TTO to understand what is covered, identifying gaps in the patent portfolio, filing new patents on commercial embodiments and improved processes as the company develops them, and sometimes acquiring freedom-to-operate in areas covered by third-party patents. This work is expensive and time-consuming but is often the most important investment a deep tech company makes in its early stages.
FailUp Capital's investment through Alumni Ventures is not just about capital — it is about network access. The alumni networks of leading universities are extraordinary assets for deep tech companies. Former researchers who have transitioned to industry roles bring domain expertise, industry connections, and often specific customers for university spinout technologies. Alumni in the VC community provide warm introductions to co-investors and help navigate the funding landscape. Alumni in operating roles at large corporations provide paths to corporate partnerships and licensing agreements that can generate revenue before a company has its own commercial infrastructure.
We actively connect our portfolio companies to relevant alumni in these networks. When a materials science spinout needs to introduce its technology to potential customers in the aerospace industry, we look for Alumni Ventures network members at Boeing, Airbus, Lockheed Martin, and related Tier 1 suppliers. When a semiconductor company needs to reach chip designers at major fabless companies, we look for network members in those organizations. This network advantage compounds over time — as our portfolio grows, so does the breadth of domains and industries we can connect our founders to.
When FailUp Capital evaluates a university spinout, we work through a specific set of questions that reflect the unique characteristics of this company type:
Technology fundamentals: Has the core scientific principle been published in peer-reviewed literature? What is the novelty and defensibility of the IP? Are the patents filed on fundamental aspects of the technology or only on specific applications? What freedom-to-operate analysis has been done?
Founder readiness: Has the founding researcher demonstrated awareness of the founder-to-CEO transition challenge? Is there a plan for acquiring or hiring commercial skills? Is the research group advisor a supportive advocate for the commercial venture or a reluctant licensor?
TTO relationship: What are the terms of the license? Is the IP assignment clean and complete? Are the royalty and milestone terms compatible with a venture-backed growth trajectory? What are the reversion rights if development milestones are missed?
Commercial validation: Has the technology been shown to potential customers? Have any letters of intent, pilot agreements, or SBIR contracts been secured? What is the response of domain experts outside the founding team to the technology's commercial potential?
FailUp Capital builds relationships with academic researchers before they formally launch their companies. If you are a PhD or post-doc considering a spinout, reach out early.
Connect With FailUp Capital